Maxime Bos

Maxime Bos is a Researcher in the Department of Epidemiology at Erasmus Medical Center. His work primarily focuses on cardiovascular epidemiology, with particular emphasis on atrial fibrillation, Mendelian randomization, and genetic studies related to cardiovascular diseases.

Dr. Bos's research interests span several key areas in cardiovascular epidemiology:

• Genetic determinants of cardiovascular diseases
• Atrial fibrillation and related conditions
• Mendelian randomization approaches
• Metabolomics in cardiovascular disease
• Large cohort studies including the Rotterdam Study and UK Biobank

His recent publication record shows a strong focus on genome-wide association studies, cardiovascular disease mechanisms, and the intersection of metabolic disorders with cardiovascular outcomes. Dr. Bos frequently collaborates with researchers across multiple international cohorts and consortia, including the LifeLines Cohort Study and the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium.

Dr. Bos has contributed to significant research in cardiovascular epidemiology, with publications in high-impact journals including the American Journal of Cardiology, Journal of the American Heart Association, Diabetes Care, and Cell Reports. His work has been cited multiple times and has received attention in news outlets and social media, indicating its relevance to the broader scientific community and public health discourse.